In June 2016, the CDC’s Advisory Committee on Immunization Practices (ACIP) made recommendations that, due to poor effectiveness of the live-attenuated influenza vaccine (LAIV, FluMist), practices should not use that form of the vaccine for the 2016-17 influenza season and should only use the injectable form, which continues to demonstrate effectiveness. The following link is an article from […]